Bengt Lindholm Selected Research

C-Reactive Protein

7/2022	Low-Plasma Insulin-Like Growth Factor-1 Associates With Increased Mortality in Chronic Kidney Disease Patients With Reduced Muscle Strength.
1/2022	First-year mortality in incident dialysis patients: results of the Peridialysis study.
3/2021	Suboptimal dialysis initiation is associated with comorbidities and uraemia progression rate but not with estimated glomerular filtration rate.
1/2021	Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5.
12/2020	Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study.
10/2020	Plant-based diets, insulin sensitivity and inflammation in elderly men with chronic kidney disease.
10/2019	Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.
1/2019	Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients.
1/2018	Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.
1/2018	Serum albumin, inflammation, and nutrition in end-stage renal disease: C-reactive protein is needed for optimal assessment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bengt Lindholm Research Topics

Disease

133	Inflammation (Inflammations) 01/2022 - 07/2000
107	Chronic Renal Insufficiency 07/2022 - 10/2003
80	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 01/2002
64	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 05/2002
32	Malnutrition (Nutritional Deficiencies) 07/2022 - 07/2000
23	Diabetes Mellitus 01/2022 - 07/2000
23	Vascular Calcification 01/2021 - 01/2005
20	Insulin Resistance 10/2020 - 01/2006
19	Atherosclerosis 01/2018 - 01/2002
15	Infections 10/2020 - 05/2002
14	Hypertension (High Blood Pressure) 07/2020 - 05/2002
13	Uremia 01/2017 - 06/2003
12	Renal Insufficiency (Renal Failure) 10/2020 - 03/2002
10	Body Weight (Weight, Body) 05/2013 - 01/2002
9	Kidney Diseases (Kidney Disease) 01/2019 - 02/2007
8	Heart Failure 04/2022 - 05/2002
8	Obesity 01/2022 - 10/2003
8	Vascular Diseases (Vascular Disease) 04/2020 - 11/2004
8	Anorexia 04/2011 - 07/2000
7	Necrosis 01/2019 - 10/2003
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2013 - 01/2008
6	Peritonitis 12/2021 - 07/2004
6	Neoplasms (Cancer) 10/2021 - 01/2008
6	Proteinuria 07/2020 - 02/2008
5	Water Intoxication 01/2022 - 01/2015
5	Hypoalbuminemia 01/2019 - 09/2002
5	Acute Kidney Injury (Acute Renal Failure) 11/2018 - 01/2010
4	Sarcopenia 08/2021 - 02/2015
4	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2021 - 05/2013
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 07/2008
4	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2017 - 01/2011
3	Myocardial Infarction 04/2022 - 10/2017
3	Stroke (Strokes) 04/2022 - 10/2017
3	Acidosis 03/2021 - 11/2004
3	Osteoporosis 06/2020 - 05/2013
3	Bone Diseases (Bone Disease) 06/2020 - 07/2009
3	Fibrosis (Cirrhosis) 01/2020 - 05/2013
3	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2018 - 05/2014

Drug/Important Bio-Agent (IBA)

58	C-Reactive ProteinIBA 07/2022 - 01/2002
57	Biomarkers (Surrogate Marker)IBA 03/2021 - 09/2004
53	Proteins (Proteins, Gene)FDA Link 08/2021 - 07/2000
34	Interleukin-6 (Interleukin 6)IBA 10/2020 - 05/2002
25	AlbuminsIBA 01/2021 - 06/2002
20	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 07/2004
19	Serum AlbuminIBA 01/2022 - 01/2002
19	CytokinesIBA 01/2017 - 01/2002
15	Insulin (Novolin)FDA Link 07/2022 - 01/2002
14	MineralsIBA 01/2021 - 06/2007
12	CreatinineIBA 11/2020 - 01/2007
12	LipidsIBA 06/2018 - 11/2004
10	alpha-2-HS-GlycoproteinIBA 01/2013 - 06/2005
9	CalciumIBA 01/2021 - 06/2005
9	CholesterolIBA 01/2018 - 01/2004
9	LeptinIBA 01/2017 - 07/2000
9	AdiponectinIBA 10/2012 - 01/2004
8	OsteoprotegerinIBA 01/2021 - 07/2005
8	HomocysteineIBA 09/2008 - 06/2002
7	Phosphates (Orthophosphate)IBA 10/2020 - 11/2006
7	Advanced Glycation End ProductsIBA 05/2016 - 06/2003
7	Advanced Oxidation Protein Products (AOPP)IBA 07/2015 - 06/2005
7	AdipokinesIBA 10/2012 - 07/2004
7	Amino Acids FDA Link 03/2010 - 06/2002
6	Insulin-Like Growth Factor I (IGF-1)IBA 07/2022 - 03/2007
6	Parathyroid Hormone (Parathormone)IBA 01/2021 - 10/2005
6	hydroxide ionIBA 01/2019 - 01/2015
6	Dialysis SolutionsIBA 01/2019 - 08/2002
6	pentosidineIBA 01/2016 - 05/2003
6	Triglycerides (Triacylglycerol)IBA 07/2015 - 01/2004
5	Uremic ToxinsIBA 11/2022 - 01/2008
5	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2005
5	calcium phosphateIBA 12/2020 - 11/2006
5	InterleukinsIBA 10/2020 - 06/2005
5	Testosterone (Sustanon)FDA Link 01/2017 - 03/2009
5	Peptides (Polypeptides)IBA 01/2013 - 02/2007
4	omega-Chloroacetophenone (Mace)IBA 04/2022 - 11/2020
4	Urea (Carbamide)FDA LinkGeneric 03/2021 - 03/2007
4	8-Hydroxy-2'-DeoxyguanosineIBA 10/2019 - 11/2006
4	Troponin T (Troponin T1)IBA 12/2016 - 01/2011
4	S100A12 ProteinIBA 05/2016 - 12/2010
4	IronIBA 01/2016 - 12/2004
4	DNA (Deoxyribonucleic Acid)IBA 03/2012 - 07/2005
4	Nicotinamide PhosphoribosyltransferaseIBA 03/2010 - 02/2007
3	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2018
3	Biological ProductsIBA 01/2021 - 10/2003
3	Alkaline PhosphataseIBA 01/2021 - 04/2017
3	PotassiumIBA 01/2021 - 01/2018
3	NF-kappa B (NF-kB)IBA 12/2020 - 06/2005
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2020 - 12/2010
3	CollagenIBA 01/2020 - 11/2009
3	Uric Acid (Urate)IBA 01/2019 - 11/2006
3	SolutionsIBA 01/2019 - 01/2009
3	Angiotensin Receptor AntagonistsIBA 10/2018 - 06/2006
3	VitaminsIBA 05/2017 - 06/2002

Therapy/Procedure

43	Renal Dialysis (Hemodialysis) 11/2022 - 01/2002
40	Peritoneal Dialysis 03/2021 - 07/2000
26	Therapeutics 03/2021 - 09/2002
16	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2021 - 07/2002
9	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2011 - 06/2002
6	Kidney Transplantation 12/2021 - 04/2013
3	Hemodiafiltration 12/2020 - 01/2013